Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Wang John — Genesis Pharmaceuticals Enterprises, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Wang John

Wang John

Director at Hambrecht Asia Acquisition Corp. · on record since Mar 7, 2008
CEO, President and Director at Hambrecht Asia Acquisition Corp. · on record since Mar 7, 2008
10% owner at Hambrecht Asia Acquisition Corp. · on record since Mar 7, 2008
Director at Genesis Pharmaceuticals Enterprises, Inc. · on record since Sep 16, 2008

Insider trading activity of Wang John

Transactions on record: 2; since Jul 29, 2010

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 29, 2010

Figures computed from official regulatory filings — methodology.

Companies where Wang John has traded

Genesis Pharmaceuticals Enterprises, Inc.2 tx · Jul 29, 2010

Track record of Wang John

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wang John

Co-insiders of Wang John

Arboleda RodrigoGenesis Pharmaceuticals Enterprises, Inc.
Cannon Stephen NHambrecht Asia Acquisition Corp.
Cao WuboGenesis Pharmaceuticals Enterprises, Inc.
Dong LiningGenesis Pharmaceuticals Enterprises, Inc.
Eu Robert JHambrecht Asia Acquisition Corp.
Feng XiaoweiGenesis Pharmaceuticals Enterprises, Inc.
Ge JianGenesis Pharmaceuticals Enterprises, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

HAMBRECHT WILLIAM RHambrecht Asia Acquisition Corp.

Huang LeiGenesis Pharmaceuticals Enterprises, Inc.

Jin LinxianGenesis Pharmaceuticals Enterprises, Inc.

Liu Hong XiangHambrecht Asia Acquisition Corp.

Marks MichaelGenesis Pharmaceuticals Enterprises, Inc.

Sung ElsaGenesis Pharmaceuticals Enterprises, Inc.

TING LEE SHambrecht Asia Acquisition Corp.

Verda International LtdGenesis Pharmaceuticals Enterprises, Inc.

Wang RenhuiGenesis Pharmaceuticals Enterprises, Inc.

WR HAMBRECHT & CO LLCHambrecht Asia Acquisition Corp.

Wu HaoHambrecht Asia Acquisition Corp.

Xin JingshengGenesis Pharmaceuticals Enterprises, Inc.

Xue HongGenesis Pharmaceuticals Enterprises, Inc.

Xu HaiboGenesis Pharmaceuticals Enterprises, Inc.

Yang WeidongGenesis Pharmaceuticals Enterprises, Inc.

Zhang YihuaGenesis Pharmaceuticals Enterprises, Inc.

Zhou GeorgeGenesis Pharmaceuticals Enterprises, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Genesis Pharmaceuticals Enterprises, Inc.	Jul 29, 2010	Award	1,250	0.00	$0	SEC
Genesis Pharmaceuticals Enterprises, Inc.	Jul 29, 2010	Award	1,143	0.00	$0	SEC